AGGRESSIVE APPROACH WITH BORTEZOMIB AND CYCLOPHOSFAMIDE, FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) AND THALIDOMIDE CONSOLIDATION, IS FEASIBLE IN OLDER PATIENTS WITH MULTIPLE MYELOMA AND CAN ACHIEVE A MYELOMA-FREE HARVEST

Abstract

Abstract is not available.